Overexpression of an Engineered SerpinB9 Enhances Allogeneic T-Cell Persistence and Efficacy.
Teo PY, Jung Y, Quach DH, Koh J, Ong RW, Goh A, Tan A, Ng CH, Seh CC, Tan KW, Horak ID, Low L.
Teo PY, et al. Among authors: quach dh.
Cancer Immunol Res. 2024 Jun 4. doi: 10.1158/2326-6066.CIR-23-1001. Online ahead of print.
Cancer Immunol Res. 2024.
PMID: 38833270